A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 27, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 20-F for FY2025, filed Mar 17, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the VALN SEC filings page.
Valneva SE (VALN) reported $205.0M in revenue for fiscal year 2025, up 16.8% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Financial Health Signals
Scored against emerging companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed: here 4 of 6, with the others left out rather than counted as zero. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Valneva SE's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Not available for Valneva SE, so it is left out of the overall score, which averages the 4 of 6 dimensions that can be computed.
Valneva SE had 174M shares outstanding at the end of fiscal year 2025, against 163M in fiscal year 2024. Dilution ranks emerging companies on how fast that count has grown over three years, where a slower rise is the better one, and Valneva SE scores 46/100 among other emerging companies.
Valneva SE spent $100.1M on research and development in fiscal year 2025, which was 33.2% of its operating costs that year. R&D Intensity ranks emerging companies on the share of operating costs that goes into research, and Valneva SE scores 65/100 among other emerging companies.
Valneva SE reported revenue of $205.0M in fiscal year 2025, against $175.5M in fiscal year 2024. Revenue Progress ranks emerging companies on the three-year path of that line, and Valneva SE scores 55/100 among other emerging companies.
Valneva SE's operations used $62.1M of cash in fiscal year 2025, against $69.6M used in fiscal year 2024. Burn Trend ranks emerging companies on which way that figure has moved over three years, and Valneva SE scores 84/100 among other emerging companies.
Not available for Valneva SE, so it is left out of the overall score, which averages the 4 of 6 dimensions that can be computed.
Valneva SE passes 2 of 9 financial strength tests. 1 of 4 profitability signals pass, no leverage/liquidity signals pass (rising debt, declining liquidity, or share dilution), 1 of 2 operating efficiency signals passes.
Valneva SE reported a net loss of $135.2M while operations used $62.1M of cash. With neither figure positive, the ratio between the two carries no quality signal.
Valneva SE reported an operating loss of $96.3M against $49.2M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations.
Key Financial Metrics
Earnings & Revenue
Valneva SE earned -$0.34 per diluted share (EPS) in Q4 2025. The change from the same quarter a year earlier is not meaningful, because that figure was zero or negative.
Not reported for Q4 2025.
Not reported for Q4 2025.
Not reported for Q4 2025.
Cash & Balance Sheet
Valneva SE recorded an outflow of $30.0M in free cash flow in Q4 2025, representing a cash shortfall after capex. This represents a decrease of 612.0% from the same quarter a year earlier. The change from the prior quarter is not meaningful, because that quarter’s figure was zero or negative.
Valneva SE held $128.7M in cash against $189.3M in long-term debt as of Q4 2025.
Not reported for Q4 2025.
Margins & Returns
None of these metrics is reported for Q4 2025.
Capital Allocation
Valneva SE invested $1.3M in capex in Q4 2025, funding long-term assets and infrastructure. This represents a decrease of 68.1% from the same quarter a year earlier. Against the prior quarter it is up 62.4%.
Not reported for Q4 2025.
Not reported for Q4 2025.
VALN Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2520-F | Q3'256-K | Q2'256-K | Q1'256-K | Q4'2420-F | Q3'246-K | Q2'246-K | Q1'246-K |
|---|---|---|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | $53.2M+50.4% | N/A | N/A | N/A | $35.3M-3.0% |
| Cost of Revenue | N/A | N/A | N/A | $24.9M+4.0% | N/A | N/A | N/A | $23.9M+7.4% |
| Gross Profit | N/A | N/A | N/A | $28.3M+147.3% | N/A | N/A | N/A | $11.4M-19.3% |
| R&D Expenses | N/A | N/A | N/A | $16.1M+13.9% | N/A | N/A | N/A | $14.2M-7.3% |
| Operating Income | N/A | N/A | N/A | -$6.4M-108.7% | N/A | N/A | N/A | $73.6Mn/m |
| Interest Expense | N/A | N/A | N/A | $6.5M-15.1% | N/A | N/A | N/A | $7.6M+37.2% |
| Income Tax | N/A | N/A | N/A | $1.6M+18333.5% | N/A | N/A | N/A | $9Kn/m |
| Net Income | N/A | N/A | N/A | -$10.0M-115.7% | N/A | N/A | N/A | $63.6Mn/m |
| EPS (Basic) | -$0.34n/m | N/A | N/A | -$0.06-114.3% | -$0.27n/m | N/A | N/A | $0.45n/m |
| EPS (Diluted) | -$0.34n/m | N/A | N/A | -$0.06-114.6% | -$0.26n/m | N/A | N/A | $0.44n/m |
Not reported in any period shown, so not listed: SG&A Expenses, EBITDA, Diluted Shares (Avg).
VALN Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2520-F | Q3'256-K | Q2'256-K | Q1'256-K | Q4'2420-F | Q3'246-K | Q2'246-K | Q1'246-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $468.1M-9.6% | $526.0M-8.6% | $556.3M+11.3% | $520.6M-4.0% | $517.6M+1.7% | $575.8M+4.5% | $499.7M-15.7% | $542.6M-15.4% |
| Current Assets | $261.2M-15.6% | $314.9M-6.9% | $335.1M+16.2% | $309.9M-6.2% | $309.5M+6.5% | $338.4M-0.3% | $288.3M-22.7% | $330.5M-21.9% |
| Cash & Equivalents | $128.7M-26.1% | $168.4M-3.4% | $189.9M+34.9% | $165.2M-13.3% | $174.2M+24.9% | $174.2M-3.9% | $140.8M-36.9% | $190.6M-31.1% |
| Inventory | $59.0M+6.1% | $75.4M+17.1% | $72.7M+38.8% | $66.6M+27.0% | $55.5M+12.9% | $64.5M+60.2% | $52.3M+43.7% | $52.4M+23.7% |
| Accounts Receivable | $32.6M-10.4% | $23.6M-30.4% | $28.4M-13.1% | $36.2M+22.9% | $36.4M-20.9% | $33.8M-27.9% | $32.7M-11.1% | $29.4M+0.2% |
| Total Liabilities | $343.5M+4.1% | $349.4M+4.8% | $336.8M+4.7% | $331.4M-2.1% | $330.0M-10.1% | $333.4M-13.2% | $321.6M-16.3% | $338.4M-19.2% |
| Current Liabilities | $109.5M-7.6% | $176.6M+45.2% | $147.9M+34.7% | $114.7M-8.5% | $118.6M-32.5% | $121.7M-47.3% | $109.8M-58.3% | $125.3M-56.2% |
| Non-Current Liabilities | $233.9M+10.7% | $172.8M-18.4% | $188.9M-10.8% | $216.8M+1.7% | $211.4M+10.5% | $211.7M+38.1% | $211.9M+75.1% | $213.1M+60.7% |
| Long-Term Debt | $189.3M+9.8% | $127.8M-25.1% | $144.0M-16.2% | $174.3M+1.6% | $172.4M+17.4% | $170.7M+50.6% | $172.0M+112.2% | $171.6M+89.7% |
| Total Equity | $124.6M-33.6% | $176.6M-27.1% | $219.4M+23.2% | $189.2M-7.3% | $187.6M+32.2% | $242.4M+45.4% | $178.1M-14.5% | $204.2M-8.3% |
Not reported in any period shown, so not listed: Short-Term Investments, Long-Term Investments, Goodwill, Retained Earnings.
VALN Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2520-F | Q3'256-K | Q2'256-K | Q1'256-K | Q4'2420-F | Q3'246-K | Q2'246-K | Q1'246-K |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -$28.8M-391.7% | -$20.5Mn/m | -$3.3Mn/m | -$8.8Mn/m | $9.9Mn/m | -$11.7Mn/m | -$40.5Mn/m | -$30.7Mn/m |
| Capital Expenditures | $1.3M-68.1% | $784K-88.1% | $1.5M+252.8% | $1.5M-68.8% | $4.0M-38.6% | $6.6M+422.3% | -$422K-88.4% | $4.9M+16.1% |
| Free Cash Flow | -$30.0M-612.0% | -$21.3Mn/m | -$4.8Mn/m | -$10.3Mn/m | $5.9Mn/m | -$18.3Mn/m | -$40.9Mn/m | -$35.5Mn/m |
| Investing Cash Flow | -$310K-106.4% | $231Kn/m | -$802K-183.6% | -$1.0M-101.1% | $4.9Mn/m | -$17.1M-785.7% | $959Kn/m | $93.6Mn/m |
| Financing Cash Flow | -$11.0Mn/m | -$652K-101.1% | $17.5Mn/m | -$6.0Mn/m | -$4.8M-111.6% | $57.8M+53.3% | -$9.8Mn/m | -$8.0Mn/m |
Not reported in any period shown, so not listed: Depreciation & Amortization, Stock-Based Compensation, Dividends Paid, Share Buybacks.
VALN Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q4'2520-F | Q3'256-K | Q2'256-K | Q1'256-K | Q4'2420-F | Q3'246-K | Q2'246-K | Q1'246-K |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | N/A | N/A | N/A | 53.2%+20.9pp | N/A | N/A | N/A | 32.3%-6.5pp |
| Operating Margin | N/A | N/A | N/A | -12.1% | N/A | N/A | N/A | 208.2% |
| Net Margin | N/A | N/A | N/A | -18.8% | N/A | N/A | N/A | 179.9% |
| Return on Equity | N/A | N/A | N/A | -5.3%-36.4pp | N/A | N/A | N/A | 31.1%+40.0pp |
| Return on Assets | N/A | N/A | N/A | -1.9%-13.6pp | N/A | N/A | N/A | 11.7%+14.8pp |
| Current Ratio | 2.38-0.2x | 1.78-1.0x | 2.27-0.4x | 2.70+0.1x | 2.61+1.0x | 2.78+1.3x | 2.63+1.2x | 2.64+1.2x |
| Debt-to-Equity | 1.52+0.6x | 0.720.0x | 0.66-0.3x | 0.92+0.1x | 0.92-0.1x | 0.700.0x | 0.97+0.6x | 0.84+0.4x |
| Liabilities-to-Equity | 2.76+1.0x | 1.98+0.6x | 1.54-0.3x | 1.75+0.1x | 1.76-0.8x | 1.38-0.9x | 1.810.0x | 1.66-0.2x |
| Asset Turnover | N/A | N/A | N/A | 0.100.0x | N/A | N/A | N/A | 0.070.0x |
| FCF Margin | N/A | N/A | N/A | -19.4% | N/A | N/A | N/A | -100.5% |
Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Valneva SE VALN | FY2025 | $205.0M | -$135.2M | -66.0% | $528.2M | 63/100 |
| Anavex Life Sciences AVXL | FY2025 | N/A | -$46.4M | N/A | $121.4M | — |
| BridgeBio Oncology Therapeutics, Inc. BBOT | FY2025 | N/A | -$134.0M | N/A | $215.7M | — |
| Inventiva S.A. IVA | FY2024 | $9.5M | -$190.7M | N/A | $870.5M | 42/100 |
| Gossamer Bio, Inc. GOSS | FY2025 | $48.5M | -$170.4M | N/A | $59.8M | 47/100 |
| GH Research PLC GHRS | FY2025 | N/A | -$48.3M | N/A | $1.4B | — |
Where Valneva SE Ranks
Frequently Asked Questions
What is Valneva SE's annual revenue?
Valneva SE (VALN) reported $205.0M in total revenue for fiscal year 2025. This represents a 16.8% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Valneva SE's revenue growing?
Valneva SE (VALN) revenue grew by 16.8% year-over-year, from $175.5M to $205.0M in fiscal year 2025.
Is Valneva SE profitable?
No, Valneva SE (VALN) reported a net loss of $135.2M in fiscal year 2025, with a net profit margin of -66.0%.
What is Valneva SE's EBITDA?
Valneva SE (VALN) had EBITDA of -$70.8M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Valneva SE have?
As of fiscal year 2025, Valneva SE (VALN) had $128.7M in cash and equivalents against $189.3M in long-term debt.
What is Valneva SE's gross margin?
Valneva SE (VALN) had a gross margin of 38.7% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Valneva SE's operating margin?
Valneva SE (VALN) had an operating margin of -47.0% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Valneva SE's net profit margin?
Valneva SE (VALN) had a net profit margin of -66.0% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Valneva SE's return on equity (ROE)?
Valneva SE (VALN) has a return on equity of -108.5% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Valneva SE's free cash flow?
Valneva SE (VALN) recorded an outflow of $67.3M in free cash flow during fiscal year 2025. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Valneva SE's operating cash flow?
Valneva SE (VALN) recorded an outflow of $62.1M in operating cash flow during fiscal year 2025, representing cash used by core business activities.
What are Valneva SE's total assets?
Valneva SE (VALN) had $468.1M in total assets as of fiscal year 2025, including both current and long-term assets.
What are Valneva SE's capital expenditures?
Valneva SE (VALN) invested $5.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Valneva SE spend on research and development?
Valneva SE (VALN) invested $100.1M in research and development during fiscal year 2025.
What is Valneva SE's current ratio?
Valneva SE (VALN) had a current ratio of 2.38 as of fiscal year 2025, which is generally considered healthy.
What is Valneva SE's debt-to-equity ratio?
Valneva SE (VALN) had a debt-to-equity ratio of 1.52 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
What is Valneva SE's liabilities-to-equity ratio?
Valneva SE (VALN) had a liabilities-to-equity ratio of 2.76 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
What is Valneva SE's return on assets (ROA)?
Valneva SE (VALN) had a return on assets of -28.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Valneva SE's P/E ratio?
Valneva SE (VALN) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (FY2025). The market capitalization is $528.2M as of Oct 27, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Valneva SE's price-to-sales ratio?
Valneva SE (VALN) trades at 2.6x sales, its market capitalization divided by $205.0M revenue, FY2025. The market capitalization is $528.2M as of Oct 27, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Valneva SE's Piotroski F-Score?
Valneva SE (VALN) has a Piotroski F-Score of 2 out of 9, indicating weak financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Valneva SE's earnings high quality?
Valneva SE (VALN) reported a net loss of $135.2M while operations used $62.1M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Valneva SE cover its interest payments?
Valneva SE (VALN) reported an operating loss of $96.3M against $49.2M in interest expense. There is no operating profit to cover interest, so interest must be met from cash reserves or from financing rather than from operations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Valneva SE?
Valneva SE (VALN) scores 63 out of 100 on our Financial Health Score, indicating moderate standing within its emerging companies peer group. The score is the average of six dimensions (Cash Runway, Dilution, R&D Intensity, Revenue Progress, Burn Trend, Balance Sheet), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. For Valneva SE it averages the 4 of 6 dimensions that can be computed; the others are left out rather than counted as zero. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.